A Multicenter, Prospective, Randomized, Open-label, Phase 4 Trial to Evaluate the Efficacy of Telmisartan/S-Amlodipine(Telminuvo Tab. 40/2.5mg) on 24-hour Ambulatory BP Control Compared With Telmisartan Monotherapy in Hypertensive Patients Inadequately Controlled by Telmisartan Monotherapy
Phase of Trial: Phase IV
Latest Information Update: 03 Aug 2017
Price : $35 *
At a glance
- Drugs Levamlodipine/telmisartan (Primary) ; Telmisartan
- Indications Hypertension
- Focus Therapeutic Use
- Acronyms TENUVA-BP
- Sponsors Chong Kun Dang
- 20 Aug 2015 Planned End Date changed from 1 Dec 2015 to 1 Apr 2016 as reported by ClinicalTrials.gov record.
- 20 Aug 2015 Planned primary completion date changed from 1 Sep 2015 to 1 Apr 2016 as reported by ClinicalTrials.gov record.
- 10 Sep 2014 New trial record